www.zenasbio.comHealthcare / BioTech & PharmaFounded: 2020
Zenas BioPharma is a biopharmaceutical company that aims to develop inflammatory and immunology therapies. The company has a mission to address the unmet needs of patients who experience autoimmune and rare diseases by discovering differentiated approaches to current treatments. The company's lead product candidate is obexelimab, which is a bifunctional monoclonal antibody that was designed to inhibit B-cell activity. Zenas BioPharma was founded in 2019 by Lonnie Moulder Jr. and is headquartered in Waltham, MA.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Zenas BioPharma.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.